US HB275 | 2019-2020 | 116th Congress

Status

Spectrum: Strong Partisan Bill (Democrat 36-2)
Status: Introduced on January 8 2019 - 25% progression, died in chamber
Action: 2019-09-25 - Subcommittee Hearings Held.
Text: Latest bill text (Introduced) [PDF]

Summary

Requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Medicare Prescription Drug Price Negotiation Act of 2019

Sponsors


History

DateChamberAction
2019-09-25HouseSubcommittee Hearings Held.
2019-01-25HouseReferred to the Subcommittee on Health.
2019-01-08HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-01-08HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-01-08HouseReferred to the Subcommittee on Health.
2019-01-08HouseIntroduced in House

Same As/Similar To

HB1346 (Related) 2019-12-10 - Subcommittee Hearings Held.

Subjects


US Congress State Sources


Bill Comments

feedback